<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C3C03463-3705-4E3B-A5AE-F754BF00EE9C"><gtr:id>C3C03463-3705-4E3B-A5AE-F754BF00EE9C</gtr:id><gtr:name>Debiopharm</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C3C03463-3705-4E3B-A5AE-F754BF00EE9C"><gtr:id>C3C03463-3705-4E3B-A5AE-F754BF00EE9C</gtr:id><gtr:name>Debiopharm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/808BF61D-3F83-4359-B564-92BED0E1B156"><gtr:id>808BF61D-3F83-4359-B564-92BED0E1B156</gtr:id><gtr:firstName>Antony</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Page</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4FD2374A-BD17-4E10-AC50-297E1AABFD28"><gtr:id>4FD2374A-BD17-4E10-AC50-297E1AABFD28</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:surname>Walkinshaw</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/77754C4E-2FAD-4B3F-906F-1A7E470D075E"><gtr:id>77754C4E-2FAD-4B3F-906F-1A7E470D075E</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300054"><gtr:id>47E1D0FC-918B-415F-AEA9-A8B59B76C90F</gtr:id><gtr:title>Immunophilins as anti-infective drug targets</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300054</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-06-22</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-06-23</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>182686</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Debiopharm</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>HCV inhibitors</gtr:description><gtr:id>2268CD07-03E4-46F1-A5A1-73029E980AEE</gtr:id><gtr:impact>consultancy with european biotech company</gtr:impact><gtr:partnerContribution>COMPOUNDS FOR TESTING</gtr:partnerContribution><gtr:piContribution>discovery and testing of new immunophilin inhibitors</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1E7F30FE-B283-4033-856C-D49C2DA530A2</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>web accessible data base composed of 5 million commercially available compounds has been developed</gtr:description><gtr:id>168356B5-BB25-405F-8BBB-2A790787574E</gtr:id><gtr:impact>The Eduliss resource has been made available on the web http://eduliss.bch.ed.ac.uk/eduliss/ and used with success by a number of groups</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EDULISS</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://eduliss.bch.ed.ac.uk/eduliss/</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34E7A76D-46E2-4F33-8D02-D2EDEDF27772"><gtr:id>34E7A76D-46E2-4F33-8D02-D2EDEDF27772</gtr:id><gtr:title>Thermodynamics of the cyclophilin-A/cyclosporin-A interaction: a direct comparison of parameters determined by surface plasmon resonance using Biacore T100 and isothermal titration calorimetry.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26b67f0841c98c1919c081a46d79e4b3"><gtr:id>26b67f0841c98c1919c081a46d79e4b3</gtr:id><gtr:otherNames>Wear MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6DB1AE3-16BC-4990-8090-F1FD433A80AA"><gtr:id>B6DB1AE3-16BC-4990-8090-F1FD433A80AA</gtr:id><gtr:title>Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using AKTAxpress.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87592b4c08689b5b81e2104a23f486d4"><gtr:id>87592b4c08689b5b81e2104a23f486d4</gtr:id><gtr:otherNames>Ludwig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14C75C1E-CADB-4E8A-AB02-B5DB9E15CFD4"><gtr:id>14C75C1E-CADB-4E8A-AB02-B5DB9E15CFD4</gtr:id><gtr:title>Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/614499d6dfd60e0aac13fcc6156c92cd"><gtr:id>614499d6dfd60e0aac13fcc6156c92cd</gtr:id><gtr:otherNames>Yang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81EEB3FE-B96B-4073-9BAC-95792A2FD1A4"><gtr:id>81EEB3FE-B96B-4073-9BAC-95792A2FD1A4</gtr:id><gtr:title>Determination of the rate constants for the FK506 binding protein/rapamycin interaction using surface plasmon resonance: an alternative sensor surface for Ni2+-nitrilotriacetic acid immobilization of His-tagged proteins.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26b67f0841c98c1919c081a46d79e4b3"><gtr:id>26b67f0841c98c1919c081a46d79e4b3</gtr:id><gtr:otherNames>Wear MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EBBF19A-38A8-41A1-A8B9-E9D57BAAA799"><gtr:id>4EBBF19A-38A8-41A1-A8B9-E9D57BAAA799</gtr:id><gtr:title>A kinetically trapped intermediate of FK506 binding protein forms in vitro: chaperone machinery dominates protein folding in vivo.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26b67f0841c98c1919c081a46d79e4b3"><gtr:id>26b67f0841c98c1919c081a46d79e4b3</gtr:id><gtr:otherNames>Wear MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5743D081-82E4-4CE3-9B4B-4E949214040F"><gtr:id>5743D081-82E4-4CE3-9B4B-4E949214040F</gtr:id><gtr:title>Cloning, expression and characterisation of FKB-6, the sole large TPR-containing immunophilin from C. elegans.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4567453a63373b55eaefe0131e8dbfb0"><gtr:id>4567453a63373b55eaefe0131e8dbfb0</gtr:id><gtr:otherNames>Richardson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A6A323C-8337-4B2D-A544-32055E7E9B13"><gtr:id>8A6A323C-8337-4B2D-A544-32055E7E9B13</gtr:id><gtr:title>Cloning, purification and characterization of the Caenorhabditis elegans small glutamine-rich tetratricopeptide repeat-containing protein.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5de380dea459f323e5976720d06511b2"><gtr:id>5de380dea459f323e5976720d06511b2</gtr:id><gtr:otherNames>Worrall LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11142A06-74FD-4067-A48C-B241204970D0"><gtr:id>11142A06-74FD-4067-A48C-B241204970D0</gtr:id><gtr:title>Experimental determination of van der waals energies in a biological system.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26b67f0841c98c1919c081a46d79e4b3"><gtr:id>26b67f0841c98c1919c081a46d79e4b3</gtr:id><gtr:otherNames>Wear MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300054</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>